FDA approves lamotrigine, a medicine for epilepsy and bipolar disorder.

The U.S. Food and Drug Administration (FDA) has given its official approval to the drug lamotrigine. This medicine is used to treat certain types of seizures in people with epilepsy. It is also approved for the long-term maintenance treatment of bipolar I disorder, to help delay future mood episodes in people who are already stable. The approval covers specific uses for adults and for children as young as 2 years old for epilepsy, and for adults with bipolar disorder. This approval formalizes the use of a treatment that doctors have prescribed for many years. It confirms the drug's role in managing these conditions according to strict federal standards for safety and effectiveness. For patients, it means this option is officially recognized and available, though it has been in use. A very important point for anyone considering this medicine is that it requires a very specific dosing plan. Starting the dose too high or increasing it too quickly can increase the risk of a serious rash. Because of this, and the need to match the treatment to a person's specific health situation, it is crucial to follow a doctor's guidance exactly. Only a healthcare provider can determine if this medicine is right for you and manage the treatment plan safely.